Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Oct 1, 2020
New York and California recognize the importance of plasma donation
The Plasma Protein Therapeutics Association (PPTA) is pleased by recent actions taken in California and New York, two of the most populous states in the country, that show the growing recognition of the importance of plasma donation.
All
PPTA statements
Oct 1, 2020
New York and California recognize the importance of plasma donation
The Plasma Protein Therapeutics Association (PPTA) is pleased by recent actions taken in California and New York, two of the most populous states in the country, that show the growing recognition of the importance of plasma donation.
All
PPTA statements
Sep 23, 2020
U.S. International Trade Commission Testimony on COVID-19 Related Goods
Oral Testimony of Amy C. Efantis, President & CEO, Plasma Protein Therapeutics Association Hearing on COVID-19 Related Goods: Conditions in the U.S. Industry and Key Supply Chains U.S. International Trade Commission.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453fa440e4694729840b893_PPTA_USITC_Testimony-COVID-19_.pdf
Sep 23, 2020
U.S. International Trade Commission Testimony on COVID-19 Related Goods
Oral Testimony of Amy C. Efantis, President & CEO, Plasma Protein Therapeutics Association Hearing on COVID-19 Related Goods: Conditions in the U.S. Industry and Key Supply Chains U.S. International Trade Commission.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453fa440e4694729840b893_PPTA_USITC_Testimony-COVID-19_.pdf
Sep 15, 2020
Proposals for revision of donor deferral criteria in the context of the COVID-19 situation in order to maintain access to plasma-derived medicinal products for patients in EU
Proposals for revision of donor deferral criteria in the context of the COVID-19 situation in order to maintain access to plasma-derived medicinal products for patients in EU
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/64522eeace0c39bce531cdfd_%2315EMA20011a_IPFA-PPTA_letter_to_EMA_Donor_acceptance_Criteria15SEP2020_Final.pdf
Sep 15, 2020
Proposals for revision of donor deferral criteria in the context of the COVID-19 situation in order to maintain access to plasma-derived medicinal products for patients in EU
Proposals for revision of donor deferral criteria in the context of the COVID-19 situation in order to maintain access to plasma-derived medicinal products for patients in EU
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/64522eeace0c39bce531cdfd_%2315EMA20011a_IPFA-PPTA_letter_to_EMA_Donor_acceptance_Criteria15SEP2020_Final.pdf
Sep 1, 2020
The Source Fall 2020
Magazine of the plasma protein therapeutics industry - Fall 2020
All
The Source Magazine
https://drive.google.com/file/d/1H5xC-s8nFHylmAxW3kjTM4oZkN-cwNv7/view?usp=sharing
Sep 1, 2020
The Source Fall 2020
Magazine of the plasma protein therapeutics industry - Fall 2020
All
The Source Magazine
https://drive.google.com/file/d/1H5xC-s8nFHylmAxW3kjTM4oZkN-cwNv7/view?usp=sharing
No results found